SARS-CoV-2 surveillance testing and isolation management of immunocompromised patients: Survey results from 13 health care centers in the United States - 21/08/24
, Mini Kamboj, MD, Tania Bubb, PhD, RN, FAPIC
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
As a newly emerging pathogen, infection prevention and isolation management response for SARS-CoV-2 varied greatly by individual health care center. Specific patient population needs, especially those of severely immunocompromised oncologic patients, potentially intensified the response. A survey was distributed to academic health care centers to ascertain surveillance testing frequency, patient placement, and isolation management for patients undergoing cell therapy treatments.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Current SARS-CoV-2 guidance lacks information for patients receiving HCTs. |
• | A survey sent to 13 transplant centers revealed heterogeneity in application of guidance. |
• | Despite differences, transmission events were not reported. |
Key Words : Infection prevention, Oncology, Positive pressure
Plan
| Conflicts of interest: None to report. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.